Exelixis
EXEL
#1759
Rank
C$16.62 B
Marketcap
C$64.03
Share price
2.09%
Change (1 day)
26.52%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company